MRGPRF

gene
On this page

Also known as MGC21621mrgF

Summary

MRGPRF (MAS related GPR family member F, HGNC:24828) is a protein-coding gene on chromosome 11q13.3, encoding Mas-related G-protein coupled receptor member F (Q96AM1). Orphan receptor.

Predicted to enable G protein-coupled receptor activity. Predicted to be involved in G protein-coupled receptor signaling pathway. Located in nuclear membrane; nucleoplasm; and plasma membrane.

Source: NCBI Gene 116535 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 75 total
  • Druggable target: yes
  • MANE Select transcript: NM_145015

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24828
Approved symbolMRGPRF
NameMAS related GPR family member F
Location11q13.3
Locus typegene with protein product
StatusApproved
AliasesMGC21621, mrgF
Ensembl geneENSG00000172935
Ensembl biotypeprotein_coding
OMIM607233
Entrez116535

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 10 protein_coding

ENST00000309099, ENST00000320913, ENST00000885480, ENST00000885481, ENST00000885482, ENST00000885483, ENST00000885484, ENST00000885485, ENST00000925381, ENST00000964385

RefSeq mRNA: 2 — MANE Select: NM_145015 NM_001098515, NM_145015

CCDS: CCDS8188

Canonical transcript exons

ENST00000309099 — 3 exons

ExonStartEnd
ENSE000012419386900439869006261
ENSE000013878456900985469009957
ENSE000022438726901308369013246

Expression profiles

Bgee: expression breadth ubiquitous, 214 present calls, max score 98.64.

FANTOM5 (CAGE): breadth broad, TPM avg 8.0469 / max 204.5209, expressed in 873 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1210236.0081840
1210221.7531552
1210240.2857179

Top tissues by expression

247 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of stomachUBERON:000119998.64gold quality
left uterine tubeUBERON:000130398.14gold quality
saphenous veinUBERON:000731897.77gold quality
body of uterusUBERON:000985397.73gold quality
urethraUBERON:000005797.58gold quality
esophagogastric junction muscularis propriaUBERON:003584197.27gold quality
myometriumUBERON:000129697.10gold quality
muscle layer of sigmoid colonUBERON:003580596.99gold quality
cauda epididymisUBERON:000436096.96gold quality
lower esophagus muscularis layerUBERON:003583396.89gold quality
endocervixUBERON:000045896.87gold quality
lower esophagusUBERON:001347396.82gold quality
nippleUBERON:000203096.52gold quality
popliteal arteryUBERON:000225095.98gold quality
tibial arteryUBERON:000761095.97gold quality
aortaUBERON:000094795.89gold quality
right coronary arteryUBERON:000162595.86gold quality
thoracic aortaUBERON:000151595.82gold quality
ascending aortaUBERON:000149695.72gold quality
descending thoracic aortaUBERON:000234595.48gold quality
pericardiumUBERON:000240794.98gold quality
smooth muscle tissueUBERON:000113594.74gold quality
ectocervixUBERON:001224994.53gold quality
vena cavaUBERON:000408794.48gold quality
left coronary arteryUBERON:000162693.94gold quality
coronary arteryUBERON:000162193.78gold quality
seminal vesicleUBERON:000099893.07gold quality
uterine cervixUBERON:000000292.78gold quality
penisUBERON:000098991.99gold quality
right ovaryUBERON:000211891.96gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-HCAD-10yes19.04
E-ANND-3yes9.03
E-HCAD-11yes7.89

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): HBP1, HIF1A, HOXB2, JUN, SP1, TBX10, ZGPAT

miRNA regulators (miRDB)

37 targeting MRGPRF, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-5582-3P99.8672.484221
HSA-MIR-444799.8567.812900
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-6756-5P99.8267.972466
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-6766-5P99.6867.702325
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-1207-5P99.4969.112983
HSA-MIR-608199.4866.071446
HSA-MIR-318299.4068.152454
HSA-MIR-5580-5P99.3866.961139
HSA-MIR-450599.2767.812678
HSA-MIR-578799.2267.862628
HSA-MIR-485-5P99.1064.781889
HSA-MIR-6884-5P99.1064.501987
HSA-MIR-4763-3P99.1067.832649
HSA-MIR-511-5P98.9770.942268
HSA-MIR-6846-5P98.8165.861121
HSA-MIR-6848-5P98.8165.491126
HSA-MIR-1178-3P98.5767.09890
HSA-MIR-518C-5P98.5369.201640
HSA-MIR-446898.0166.851187
HSA-MIR-6748-3P97.2065.66836
HSA-MIR-939-5P97.1065.801579
HSA-MIR-505-5P97.0165.54778
HSA-MIR-3059-3P96.7167.08606

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusMrgprfENSMUSG00000031070
rattus_norvegicusMrgprfENSRNOG00000013426

Paralogs (10): MAS1 (ENSG00000130368), MRGPRX1 (ENSG00000170255), MRGPRD (ENSG00000172938), GPR152 (ENSG00000175514), MRGPRX4 (ENSG00000179817), MRGPRX3 (ENSG00000179826), MRGPRG (ENSG00000182170), MRGPRX2 (ENSG00000183695), MRGPRE (ENSG00000184350), MAS1L (ENSG00000204687)

Protein

Protein identifiers

Mas-related G-protein coupled receptor member FQ96AM1 (reviewed: Q96AM1)

Alternative names: G-protein coupled receptor 140, G-protein coupled receptor 168

All UniProt accessions (2): Q96AM1, F5H5R4

UniProt curated annotations — full annotation on UniProt →

Function. Orphan receptor. May bind to a neuropeptide and may regulate nociceptor function and/or development, including the sensation or modulation of pain.

Subcellular location. Cell membrane.

Similarity. Belongs to the G-protein coupled receptor 1 family. Mas subfamily.

RefSeq proteins (2): NP_001091985, NP_659452* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000276GPCR_RhodpsnFamily
IPR017452GPCR_Rhodpsn_7TMDomain
IPR026228MRGPCRFFamily
IPR026234MRGPCRFAMILYFamily

Pfam: PF00001

UniProt features (19 total): topological domain 8, transmembrane region 7, chain 1, region of interest 1, glycosylation site 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96AM1-F180.580.52

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (1): 4

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 96 (showing top): GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP, RNGTGGGC_UNKNOWN, AP1_01, FREAC2_01, WWTAAGGC_UNKNOWN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, CHANDRAN_METASTASIS_DN, chr11q13, CAGCTG_AP4_Q5, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, SRF_Q5_01, CREB_Q4, SRF_C, FREAC3_01, HEN1_01

GO Biological Process (2): G protein-coupled receptor signaling pathway (GO:0007186), signal transduction (GO:0007165)

GO Molecular Function (1): G protein-coupled receptor activity (GO:0004930)

GO Cellular Component (5): nucleoplasm (GO:0005654), plasma membrane (GO:0005886), nuclear membrane (GO:0031965), ciliary transition zone (GO:0035869), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
G protein-coupled receptor activity1
signal transduction1
cell communication1
cellular process1
signaling1
regulation of cellular process1
cellular response to stimulus1
transmembrane signaling receptor activity1
G protein-coupled receptor signaling pathway1
nuclear lumen1
membrane1
cell periphery1
nucleus1
nuclear envelope1
organelle membrane1
cilium1

Protein interactions and networks

STRING

832 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MRGPRFNPFFO15130822
MRGPRFOR7C2O60412507
MRGPRFCOPZ2Q9P299458
MRGPRFZDHHC13Q8IUH4441
MRGPRFOR5C1Q8NGR4440
MRGPRFMYEOVQ96EZ4435
MRGPRFVGLL3A8MV65422
MRGPRFATOH8Q96SQ7421
MRGPRFPRRX2Q99811415
MRGPRFEFEMP2O95967402
MRGPRFGRM3Q14832399
MRGPRFFKBP10Q96AY3398
MRGPRFCOL16A1Q07092398
MRGPRFCOL1A2P02464388
MRGPRFTGFB1I1O43294388

IntAct

6 interactions, top by confidence:

ABTypeScore
MRGPRFRAMP3psi-mi:“MI:0915”(physical association)0.400
ESYT2psi-mi:“MI:0914”(association)0.350
E5ESYT2psi-mi:“MI:0914”(association)0.350

BioGRID (8): MRGPRF (Affinity Capture-MS), MRGPRF (Affinity Capture-MS), MRGPRF (Affinity Capture-MS), MRGPRF (Affinity Capture-MS), USP45 (Affinity Capture-Western), MRGPRF (Affinity Capture-Western), MRGPRF (PCA), MRGPRF (Reconstituted Complex)

ESM2 similar proteins: P04201, P12526, P23749, P30554, P35410, P59534, P59535, Q3KNA1, Q3UG50, Q3UG61, Q4VHE7, Q645S5, Q645U4, Q645Y7, Q645Y8, Q645Y9, Q646A9, Q646B0, Q646C8, Q646D3, Q646F0, Q646F1, Q67ER9, Q67ES7, Q67ET0, Q67ET2, Q7TN38, Q7TN41, Q7TN44, Q7TN51, Q7TQA5, Q7TQA6, Q7TQB8, Q8CIP3, Q8R4G1, Q8TDS7, Q8VCJ6, Q91WW2, Q91WW3, Q91ZB8

Diamond homologs: B9VR26, O55197, O88680, P04201, P12526, P23749, P30554, P35410, Q16581, Q2LL16, Q3KNA1, Q3UG50, Q3UG61, Q4QXU0, Q4QXU2, Q4QXU3, Q4QXU4, Q4QXU5, Q4QXU6, Q4QXX9, Q5REI5, Q5U9D9, Q6L786, Q6TAC8, Q6XKD3, Q7TN38, Q7TN39, Q7TN40, Q7TN41, Q7TN44, Q7TN45, Q7TN49, Q7TN50, Q7TN51, Q86SM5, Q8CIP3, Q8NGA4, Q8R4G1, Q8TDS7, Q8VCJ6

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

75 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance66
Likely benign2
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

459 predictions. Top by Δscore:

VariantEffectΔscore
11:69006257:CACAT:Cacceptor_gain1.0000
11:69006259:CAT:Cacceptor_gain1.0000
11:69006262:CT:Cacceptor_loss1.0000
11:69009953:CCCAC:Cacceptor_gain1.0000
11:69009954:CCACC:Cacceptor_gain1.0000
11:69009956:ACCTG:Aacceptor_loss1.0000
11:69009958:C:CAacceptor_loss1.0000
11:69006258:ACAT:Aacceptor_gain0.9900
11:69006259:CATC:Cacceptor_gain0.9900
11:69006260:AT:Aacceptor_gain0.9900
11:69006262:C:CCacceptor_gain0.9900
11:69006265:C:CTacceptor_gain0.9900
11:69006267:CAGG:Cacceptor_gain0.9900
11:69006270:G:Cacceptor_gain0.9900
11:69006270:G:GCacceptor_gain0.9900
11:69009849:CTTA:Cdonor_loss0.9900
11:69009850:TTACC:Tdonor_loss0.9900
11:69009851:TA:Tdonor_loss0.9900
11:69009852:ACC:Adonor_loss0.9900
11:69009955:CAC:Cacceptor_gain0.9900
11:69009962:C:CTacceptor_gain0.9900
11:69009963:A:Tacceptor_gain0.9900
11:69009970:C:CTacceptor_gain0.9900
11:69012412:A:ACdonor_gain0.9900
11:69012413:C:CCdonor_gain0.9900
11:69013078:GCTAC:Gdonor_loss0.9900
11:69013079:CTACC:Cdonor_loss0.9900
11:69013080:TACCT:Tdonor_loss0.9900
11:69013081:ACCT:Adonor_loss0.9900
11:69013082:C:Gdonor_loss0.9900

AlphaMissense

2221 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
11:69005426:C:TG295E0.989
11:69006138:C:GG58R0.988
11:69005375:C:GR312P0.987
11:69005447:G:CP288R0.986
11:69005447:G:TP288H0.986
11:69005475:A:GC279R0.986
11:69005808:A:GW168R0.986
11:69005808:A:TW168R0.986
11:69005439:A:CY291D0.984
11:69005455:G:CS285R0.984
11:69005455:G:TS285R0.984
11:69005457:T:GS285R0.984
11:69005566:G:CF248L0.984
11:69005566:G:TF248L0.984
11:69005568:A:GF248L0.984
11:69006147:A:GC55R0.984
11:69005441:A:TV290D0.983
11:69006025:G:CS95R0.983
11:69006025:G:TS95R0.983
11:69006027:T:GS95R0.983
11:69006137:C:TG58D0.983
11:69005427:C:GG295R0.981
11:69005427:C:TG295R0.981
11:69005453:G:TA286D0.981
11:69005469:A:GC281R0.981
11:69005896:G:CS138R0.981
11:69005896:G:TS138R0.981
11:69005898:T:GS138R0.981
11:69006124:G:CN62K0.981
11:69006124:G:TN62K0.981

dbSNP variants (sampled 300 via entrez): RS1000005074 (11:69014742 G>A,T), RS1000439978 (11:69015004 A>G), RS1000737094 (11:69012962 C>T), RS1000849518 (11:69011059 G>C), RS1001530743 (11:69008675 G>A,C), RS1001563367 (11:69008934 A>T), RS1002094691 (11:69013588 C>T), RS1002137097 (11:69007559 A>T), RS1002170229 (11:69011932 C>A,T), RS1002836416 (11:69013924 C>A,T), RS1003238970 (11:69007706 T>G), RS1003367817 (11:69012683 A>T), RS1003407068 (11:69008848 G>A), RS1003846107 (11:69008618 C>T), RS1004247755 (11:69009134 G>A)

Disease associations

OMIM: gene MIM:607233 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL4523903 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: gpcr — Class A Orphans with no pharmacology

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, increases expression, decreases expression, increases methylation4
entinostatincreases expression, affects cotreatment2
Phenylmercuric Acetateaffects cotreatment, increases expression2
methylmercuric chlorideincreases expression1
pirinixic acidincreases expression, affects binding, increases activity1
sodium arseniteincreases expression, increases abundance1
mercuric bromideincreases expression, affects cotreatment1
perfluorooctane sulfonic aciddecreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, increases expression1
dorsomorphinaffects cotreatment, increases expression1
Resveratrolaffects cotreatment, decreases expression1
Temozolomidedecreases expression1
Air Pollutantsdecreases expression, increases abundance1
Arsenicincreases abundance, increases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Carbamazepineaffects expression1
Dexamethasoneincreases expression1
Estradiolincreases expression1
Plant Extractsaffects cotreatment, decreases expression1
Triclosandecreases expression1
Cadmium Chlorideincreases expression1
Particulate Matterdecreases expression, increases abundance1

ChEMBL screening assays

2 unique, capped per target: 2 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL4883533BindingPRESTO-Tango GPCRome screening (MRGPRF)Data for DCP probe UCSF924

Cellosaurus cell lines

1 cell lines: 1 spontaneously immortalized cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_KY47PathHunter CHO-K1 MRGPRF beta-arrestinSpontaneously immortalized cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.